Lee Y S, Wurster R D
Department of Neurological Surgery, Loyola University Medical Center, Maywood, IL 60153, USA.
Toxicol Lett. 1995 Jun;78(1):67-71. doi: 10.1016/0378-4274(94)03235-y.
Deferoxamine (DFO) caused decreased viability of human neuronal tumor cells (SK-N-MC neuroblastoma and U-373 MG astrocytoma) in a dose-dependent manner. The addition of stoichiometric amounts of ferric ions did not decrease the cytotoxic effect of DFO on the neuroblastoma cells. However, the cotreatments with various antioxidants, hydroxyl radical scavengers or intracellular Ca2+ release blockers significantly protected against the effects of DFO. These results suggest that DFO-induced cytoxicity may be not due to chelating iron, but due to the production of hydroxyl radicals and that intracellular Ca2+ may play a role in the cytotoxic effects of DFO.
去铁胺(DFO)以剂量依赖的方式导致人神经肿瘤细胞(SK-N-MC神经母细胞瘤和U-373 MG星形细胞瘤)的活力下降。加入化学计量的铁离子并未降低DFO对神经母细胞瘤细胞的细胞毒性作用。然而,与各种抗氧化剂、羟基自由基清除剂或细胞内Ca2+释放阻滞剂共同处理可显著保护细胞免受DFO的影响。这些结果表明,DFO诱导的细胞毒性可能不是由于螯合铁,而是由于羟基自由基的产生,并且细胞内Ca2+可能在DFO的细胞毒性作用中起作用。